← Back to Clinical Trials
Recruiting NCT07546084

NCT07546084 The Effect of an Exercise Program Based on Attentional Focus Shifting on Clinical Outcomes in Rotator Cuff Related Shoulder Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07546084
Status Recruiting
Phase
Sponsor Istanbul University
Condition Rotator Cuff Related Shoulder Pain
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2026-05-15
Primary Completion 2027-05-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Patient EducationAttention Shift-Based Exercise TherapyStandard Exercise Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2026-05-15 with a primary completion date of 2027-05-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this clinical trial is to investigate the effects of an attention shift-based rehabilitation program on clinical outcomes in individuals with rotator cuff-related shoulder pain (RCRSP). The study will evaluate the effects of an attention shift approach, in which motor tasks targeting regions outside the shoulder are performed concurrently with standard shoulder exercises, on pain, functional status, and pain catastrophizing. These results will be compared with those of a standard shoulder rehabilitation program. The main questions this study aims to answer are: Is there a difference in pain levels between individuals with RCRSP who participate in an attention shift-based rehabilitation program and those who participate in a standard exercise program? Is there a difference between these two rehabilitation approaches in terms of shoulder function and pain catastrophizing? Participants will: Be randomly assigned to either an attention shift-based rehabilitation group or a standard shoulder rehabilitation group Participate in supervised exercise sessions twice per week for 6 weeks Attend sessions lasting approximately 60-75 minutes Undergo clinical assessments at baseline and at week 6

Eligibility Criteria

Inclusion Criteria: * Having symptoms persisting for at least 3 months * Experiencing pain intensity of at least 3 on the Numeric Pain Rating Scale (NPRS) during activity * Presence of a painful arc during shoulder flexion or abduction * Positive Neer test or Hawkins-Kennedy test * Pain provoked by resisted external rotation/abduction of the humerus, or a positive Jobe (Empty Can) test * Having a clinical diagnosis of subacromial pain syndrome, rotator cuff tendinopathy, subacromial bursitis, or symptomatic partial/full-thickness rotator cuff tear * Being able to understand and complete questionnaires in Turkish Exclusion Criteria: * Presence of adhesive capsulitis (≥30% limitation in passive range of motion) * Advanced osteoarthritis of the shoulder * History of fracture or dislocation affecting the shoulder region * Advanced acromioclavicular joint pathology * Massive rotator cuff tear (positive lag signs) * Previous shoulder surgery * Presence of neurological disorders * Diagnosis of rheumatoid arthritis * History of cancer * Symptomatic cervical spine pathology * Corticosteroid injection to the shoulder within the past 6 weeks * Cognitive impairments that may interfere with the ability to perform clinical tasks or execute attention shift-based exercises

Contact & Investigator

Central Contact

Rezzan Atay, Bachelor's degree

✉ rezzan.atay@ogr.iuc.edu.tr

📞 90+ 505 485 75 49

Frequently Asked Questions

Who can join the NCT07546084 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Rotator Cuff Related Shoulder Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07546084 currently recruiting?

Yes, NCT07546084 is actively recruiting participants. Contact the research team at rezzan.atay@ogr.iuc.edu.tr for enrollment information.

Where is the NCT07546084 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07546084 clinical trial?

NCT07546084 is sponsored by Istanbul University. The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology